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Summary
Objective: Statistical analysis is ubiquitous in medical research, but fundamental statistical principles are not always well understood, which
has negative effects for both authors and readers of scientiﬁc papers. The purpose of this brief review is to provide a methodological overview
on populations, samples, analysis units and sampling uncertainty to facilitate an increased understanding of statistical concepts.
ª 2009 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Statistical analysis plays a central role in medical research.
With exception for case reports, P-values and signiﬁcance
statements appear in almost all published papers. However,
deeper insight into statistical principles seems not wide-
spread1. P-values and signiﬁcance statements often appear
to be interpreted as obscure properties of examined pa-
tients; differences between groups exist only if statistically
signiﬁcant; the interpretation of clinical and statistical signif-
icance is confused, etc.
Understanding basic principles is necessary both for sta-
tistically analyzing data and for interpreting the results of
the analyses. Without this understanding severe mistakes
are easily made. A few minutes spent on statistical funda-
mentals may be an investment with an exceptionally high re-
turn of the invested time. This is the reason OAC plans
a series of short methodological reviews, of which this is
the ﬁrst.Random sampling
Human subjects have varying characteristics. Repeated
sampling of subjects produces samples with slightly differ-
ent properties. The degree of the heterogeneity depends
on the distribution of the characteristics in the population
and on sample size. The potential inﬂuence of sampling un-
certainty on an observation can be calculated using the in-
formation in a sample and is usually described by a P-value
or a conﬁdence interval.
The calculation of sampling uncertainty is based on the
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1416by random sampling from a deﬁned population. Random
sampling has a clear deﬁnition: All units of the population
have had a known (usually equal) probability of being sam-
pled and all units have been sampled independently.
In the world of clinical and epidemiological research study
populations are typically not sampled randomly, because
there is usually no population with known sampling proba-
bilities to sample from. Data are instead collected where
they happen to be available, for example among consecu-
tive patients, neighborhood controls, regional or national
registers, etc. Such study populations can be characterized
as convenience samples2.
No sampling uncertainty exists when a sample is as-
sumed to constitute an entire population of its own.
P-values and conﬁdence intervals can then of course not
be interpreted as measures of sampling uncertainty. How-
ever, imperfection in measurement instrument and clerical
errors in data registration, may still cause uncertainty in ob-
served ﬁndings. This measurement uncertainty may have
formidable consequences3, why an evaluation using statis-
tical methods may be pertinent.
Whenattempting tounderstandclinical ﬁndings inasample
of carefully examined patients and generalizing these ﬁnd-
ings to other individuals, which have not been included in
the examined sample, sampling uncertainty can be seriously
misleading and should always be evaluated. The required
statistical methods are based on assumptions of random
sampling, also for convenience samples. It is then simply as-
sumed that the selectionmechanism behind the speciﬁc con-
venience sample have identiﬁed a group of subjects, which in
all respects can be considered a random sample.
In clinical and epidemiological research the underlying
assumptions of known sampling probabilities and indepen-
dent sampling play critical roles in the development of
a sound study design.Types of populations
Problems arise when a convenience sample has different
properties than a hypothetical random sample would have
1417Osteoarthritis and Cartilage Vol. 17, No. 11had. These problems can easiest be explained vis-a`-vis the
hypothetical population from which the two samples could
be assumed to have be drawn.
Two different types of populations can be considered:
ﬁnite- and super-populations. Let us consider a ﬁctitious
convenience sample and discuss what populations this
sample could have been sampled from.
Assume that 50 consecutive patients being treated for os-
teoporosis with a particular treatment have been sampled
from Lund University Hospital during March and April 2005.
Figure 1 presents the presented phenomena graphically.THE FINITE POPULATION APPROACHA ﬁnite population is real. It could be deﬁned as all pa-
tients treated for osteoporosis with the particular treatment
at Lund University Hospital during 2003e2007. All these pa-
tients exist and can be identiﬁed. They have visited the hos-
pital in person and been registered there.
If the patients in the sample differ systematically from
patients not sampled, for example if male patients have
a sampling probability of zero, generalizations from the
convenience sample would lack external validity
(representativity).
Patients treated duringMarch and April 2005 could also be
more alike, with respect to some speciﬁc characteristic, than
patients treated during other time periods. For example, they
may have had a decreased probability of fragility fractures
because the winter was unusually mild. If this decreased
the variation of bone mineral density (BMD) among the pa-
tients in the sample, this could be seen as a cluster andFig. 1. A super- and a ﬁnite population of osteoporosis patients (symboliz
meaningful characteristic; the ﬁnite population deﬁned by the continuous
gles) have been drawn from the ﬁnite population. While the ﬁnite popula
sampled units by the varying proportion of white dots, one sample having
is inﬁnitely large it cannot be described graphically, but if the two ﬁnite s
population, its proportion of white dots can be estimated to 8% (2.2%e1
brackets are 95% conﬁdence intervals da violation of the independent sampling assumption. Vari-
ance estimates could then be underestimated.
Generalizations beyond the deﬁned ﬁnite population
would of course be inadequate. Finite population deﬁnitions
are common in censuses but exceptions in medical re-
search. This can be easily veriﬁed by checking if a ﬁnite
population is explicitly stated or if the statistical calculations
include adjustments for the fraction of patients sampled.THE SUPER-POPULATION APPROACHIn contrast to ﬁnite populations a super-population is al-
ways hypothetical. It constitutes an inﬁnite universe of imag-
inary units. In our example it could be the set of all patients
that have been, will be, or could have been, treated for os-
teoporosis with the particular treatment.
The assumptions of representativity and independence
are as important for this super-population as for the ﬁnite
population. If the assumptions are fulﬁlled a convenience
sample leads to the same result as a random sample
from the super-population.THE INTERPRETATION OF AN OBSERVATION IN A SAMPLEWhile sampling uncertainty may be easily recognized as
an important concept in itself, its consequences for the in-
terpretation of observed ﬁndings is, however, often
neglected.
For example, in a randomized clinical trial with patients
who had a single chronic symptomatic cartilage defect on
the femoral condyle4, 40 patients were treated withed by black and white dots; white dots representing some clinically
frame). Two random samples of 50 patients each (the gray rectan-
tion has 10% white dots, sampling uncertainty is manifested in the
8% (4 of 50), the other one 16% (8 of 50). As the super-population
amples can be assumed to be randomly sampled from the super-
9.2%) and to 16% (7.2%e29.1%), respectively. The range within
escribing the sampling uncertainty.
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with microfracture.
At the 5-year follow-up, there were nine failures in each of
the two groups. The authors observed and concluded that
‘‘there was no signiﬁcant difference’’.
However, even if no difference can be observed in the
sample, there may well be one in the population. Sampling
of patients with individually varying failure rates may pre-
vent a true average treatment difference from being ob-
served in the sample.
The sampling uncertainty can be described by a 95%
conﬁdence interval for the estimated true failure rate ra-
tio. Using the data presented in the paper the interval
can be calculated as (0.3e3.2), which implies that ob-
served data actually only speaks against an average fail-
ure rate difference in the population greater than about
300%.
A claim that the two treatments have the same failure
rates would thus not have much empirical basis.The population is important for the statistical
analysis
Super-populations are seldom explicitly deﬁned, but do-
ing so may be a good exercise for avoiding unit of analysis
errors. Many orthopedic papers present statistical analy-
ses of joints or cells and of phantom measurements, and
errors in analyses of hips, knees, hands, feet, shoulders
and elbows appears, according to a recently published
systematic review5, to be a surprisingly common problem;
of the 142 reviewed papers 42% involved unit of analysis
errors.
What populations are involved in these studies? What rel-
evance have the reasoning on super-populations on the
statistical analysis? Three examples of common study situ-
ations will be discussed.
First, an experimental unit, and the unit of analysis in the
statistical analysis, is usually deﬁned as the smallest amount
of experimental material that can be independently assigned
to a treatment. It can be patients in clinical studies, animals in
in vivo studies and cell cultures in in vitro studies6.
If independent subjects (or animals) contribute multiple
observations to a sample, and within-subject variance is
less than between-subject variance, observations are not
independent. This violates the independence assumption
of random sampling.
Example 1 What super-population is relevant when studying
two groups of ﬁve patients each, treated for osteoporosis with
drugs A and B, who have had the increase in BMD in percent
measured in their left tibia (L). Observations from ﬁve right tib-
iae (R) of the same patients have also been included.
Drug A A A A A B B B B B A A B B B
Patient 1 2 3 4 5 6 7 8 9 10 1 4 8 9 10
Tibia L L L L L L L L L L R R R R R
BMD 4.2 2.1 3.3 4.5 8.7 6.1 9.9 5.4 6.1 8.1 2.9 5.1 3.7 6.3 7.7Ignoring that some patients contribute two observations
each, the number of observations is 15 and the between-
patient variance in BMD 4.0.
When tested with Student’s t-test, the 2.3%-units in-
crease in BMD among patients treated with drug B, as com-
pared to those treated with drug A is shown to be
statistically signiﬁcant, P< 0.05.However, the dataset includes only 10 patients, and as-
sessing variation among both patients and tibiae within
patients using a mixed effects model7 shows that Stu-
dent’s t-test under-estimates the between-patient vari-
ance, because of the contamination with within-patient
variance. Separating within and between-patient variance
shows that the latter is 4.8, not 4.0. The intraclasscorrela-
tion coefﬁcient can be calculated to 0.9.
Furthermore, the correct analysis shows that the in-
crease in BMD is slightly greater (2.4%-units instead of
2.3%-units) but fails to reach statistical signiﬁcance. The
correct P-value is 0.13 instead of <0.05. The super-popu-
lation of independent analysis units in this example is of
course patients, not measurements.
Example 2 The deﬁnition of experimental unit often causes
controversies in experimental research. What super-popu-
lation should be considered when statistically analyzing
cells?
Again, the principle is that the analysis unit should be
the smallest amount of experimental material that can be
independently assigned to a treatment. The principle is,
unfortunately, not always appreciated in laboratory
research.
It is, for example, reported in a systematic review of sub-
fertility trials8 that 82% of the 39 reviewed papers had unit
of analysis errors. Live birth rates are often reported per
started cycle, per oocyte collection and per embryo trans-
fer, but not as appropriate per person rates.
For a cell to be regarded as an independent experi-
mental unit, it would have to be possible to assign inde-
pendent cells to different treatments. Cells sampled and
treated together with other cells in a cell culture on
a dish are not independent, and would therefore not be
meaningful as elements of the discussed super-
population.
Independence between analysis units is the key. A spe-
ciﬁc recommendation for dealing with this in practice is to
consider whether a proposed analysis unit really can be
treated and sampled independently of other analysis units.
Sampling individual cells, or groups of cells, from a dish
where all cells have been exposed to a common treatment
does not generate independent samples. They are related
by the common treatment, and should be regarded as re-
peated observations from this treatment, like BMD mea-
surements from the right and left tibia of the same
patient represent this patient’s BMD, not different relation-
ships between treatment and BMD.
The independence assumption is an issue that may
need to be addressed thoroughly. A motivation for the def-
inition of experimental unit is often, or should be, re-
quested by reviewers during the peer review process.
Example 3 What super-population corresponds to a series
of measurements using a mechanical device especially de-
veloped for simulating a clinical phenomenon?
For evaluating sampling uncertainty, more than one de-
vice would have to be constructed. Let us assume that
such variation of devices has no clinical relevance. P-values
and conﬁdence intervals related to only one experimental
unit do not refer to sampling uncertainty but to measurement
uncertainty, and it would probably facilitate many readers’ in-
terpretation of the presentation if the measurement uncer-
tainty was expressed in terms of accuracy or reliability
instead of P-values.
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the measurements that can or could be performed using the
developed device.Recommendations
When designing laboratory experiments, clinical trials
and observational studies, consider carefully which sample
unit is adequate and what population is at hand.
Then consider what sample size would be sufﬁcient, with-
out being unnecessarily large, to avoid an outcome that is
inconclusive because of too much sample uncertainty.
This can, and should, be calculated during the planning
stages of a study.
In some cases collection of dependent data may be ad-
vantageous. Repeated measurements on analysis units
can for example be used to provide a better estimate of be-
tween-subject variance than that available from a single
measurement. Matching controls to cases in a case-control
study to increase internal validity is another example.
The statistical analysis in such studies need, however, to
account for the dependencies in data. Which statistical
method to use for a speciﬁc purpose depends to a great ex-
tent on factors like study design, data structure, adequacy
of distributional assumptions, and the needs to address
multiplicity issues.
Selecting the right choice may not be trivial. The reader is
recommended to discuss speciﬁc applications with a profes-
sional statistician.
When presenting data in a study with dependent obser-
vations, always describe both number of independent ex-
perimental units and the number of observations. This
information is necessary for assessing the correct number
of degrees of freedom.When presenting results, use 95% conﬁdence intervals to
describe the sampling uncertainty. Conﬁdence intervals are
more informative than P-values, because the conﬁdence in-
tervals provide easily interpretable uncertainty limits in
terms of the analyzed variable’s measurement units.
Finally, the aim of this short methodological review has
been to provide an overview on the nature of uncertainty
in medical research. Basic statistical principles and their re-
lation to uncertainty are important for both authors and
readers. Understanding them is necessary for rational inter-
pretation and communication of scientiﬁc ﬁndings.
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